Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid vs Pamidronate in transplant-related osteopenia
NCT00164008Phase 4Completed
- Start
- Oct 2002
- Primary completion
- Dec 2005
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of zoledronic acid in osteopenia and osteoporosis (2 arms). Primary endpoint: Bone mineral density of lumbar spine at 12 months. Started Oct 2002; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteopeniaosteoporosis
Beyond the preview
Go deeper on NCT00164008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00164008.